Osteoporosis is a risk. ..a lot of the risk of the aramatose inhibitors are the same risks women face going through menopause. Each sort may have slightly different risks so you woukd have to see dependent on which they prescribe. Then you need to weigh up the risk of side effects against recurrence. There is a tool called Predict ...which you can pkug in info and it shows 5 and 10 year differences dependent on parh results and treatment. It is a bit broad but helps a bit in relooking at what the speciakist have said already.
If you want to tag someone directly regarding a question just do an @ prior there user name ...like @Myjourney